Should I buy DuPont (DD) stock or is it too late?

DuPont · Materials · price $130

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (185 calls tested). It aims for $172 (+33 %), call made on October 6, 2026, maturing on October 6, 2027 (8 d ago).

The 5 reliable analysts $162+25 %

The 2 other firms $305+135 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $162 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on DuPont

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
UBS	79 %	+51.0 %	14	$172 +33%
Keybanc	71 %	+42.3 %	14	$171 +32%
JP Morgan	75 %	+26.0 %	12	$145 +12%
Citigroup	70 %	+22.6 %	23	$162 +25%
BMO Capital	88 %	+21.5 %	8	$180 +39%
RBC Capital	81 %	+19.9 %	16	$176 +36%
Deutsche Bank	62 %	+18.6 %	24	$174 +34%
Wells Fargo	76 %	+18.3 %	17	$165 +27%

In short — Should you invest in DuPont? Is it too late, still worth it? Analysts are fairly positive (57% buy, median target $162, i.e. +25%), and the most reliable on DD targets even higher. But the valuation is stretched (P/E ~35). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $162, i.e. +25% from the current price ($130).
The most reliable firm on DD, BMO Capital (88% hit rate, 8 scored calls), targets $180 (call made on February 12, 2026, maturing on February 12, 2027) (+39%) in its most recent call, and $150 (call made on November 3, 2025, maturing on November 3, 2026) (+16%) in the one coming due soonest.
Pays a dividend (1.7% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 7 ratings, 3 are neutral.
High valuation (P/E ~35): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on DD

Median target $162 (+25%) · 7 ratings · Buy consensus

Strong Buy00%

Buy457%

Hold343%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in DuPont now?

We won't decide for you. The facts: 57% of analysts rate it a buy, median target $162 (+25%), and BMO Capital (most reliable on DD, 88%) targets $180. Weigh that against valuation (P/E ~35). This is not personalized advice.

Is it too late to invest in DuPont?

Not according to analysts: the median target ($162) is still +25% above the current price ($130) (most reliable on DD: BMO Capital, 88%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is DuPont still worth investing in?

It depends on the gap between the price ($130) and its estimated value: analysts target $162 on median (+25%), with 57% buys (most reliable on DD: BMO Capital, 88%). Cross-check with their real reliability on DD and the cautions above. Information, not advice.

What's the main risk in buying DD?

The consensus is not unanimous: of 7 ratings, 3 are neutral.

→ Go deeper: the full DuPont profile (consensus, analyst reliability, price target, performance).